This phenomena is accompanied by heterogeneous N-cadherin and consistent E-cadherin expression, which is commonly used for EMT assessment in PCa [33], within similar areas of tissue from two PCa patient samples previously used for surface profiling (Fig. 4A and B). The gene discussed is CDH2; the disease is posterior cortical atrophy.